Sabir Fakhara et al. Quality-by-Design-Based Development of n-Propyl-Gallate-Loaded Hyaluronic-Acid-Coated Liposomes for Intranasal Administration. (2021) MOLECULES 1420-3049 1420-3049 26 5 p. 1429,
31910259
Szakcikk (Folyóiratcikk) | Tudományos[31910259]
* Németh Zsófia et al. An Updated Risk Assessment as Part of the QbD-Based Liposome Design and Development. (2021) PHARMACEUTICS 1999-4923 1999-4923 13 7 p. 1071
* Sabir Fakhara et al. Development and Characterization of n-Propyl Gallate Encapsulated Solid Lipid Nanoparticles-Loaded Hydrogel for Intranasal Delivery. (2021) PHARMACEUTICALS 1424-8247 14 7
Hussein Hanaa Ali et al. Novel drug delivery systems based on silver nanoparticles, hyaluronic acid, lipid nanoparticles and liposomes for cancer treatment. (2021) APPLIED NANOSCIENCE 2190-5509 2190-5517
Schlich Michele et al. Design and development of topical liposomal formulations in a regulatory perspective. (2021) DRUG DELIVERY AND TRANSLATIONAL RESEARCH 2190-393X 2190-3948
Lombardo D. et al. Methods of Liposomes Preparation: Formation and Control Factors of Versatile Nanocarriers for Biomedical and Nanomedicine Application. (2022) PHARMACEUTICS 1999-4923 1999-4923 14 3 p. 543
* Katona Gábor et al. Development of Lomustine and n-Propyl Gallate Co-Encapsulated Liposomes for Targeting Glioblastoma Multiforme via Intranasal Administration. (2022) PHARMACEUTICS 1999-4923 1999-4923 14 3
Katona Gábor et al. Development of Meloxicam-Human Serum Albumin Nanoparticles for Nose-to-Brain Delivery via Application of a Quality by Design Approach. (2020) PHARMACEUTICS 1999-4923 12 2,
31142665
Szakcikk (Folyóiratcikk) | Tudományos[31142665]
Shah P. et al. Evaluations of quality by design (QbD) elements impact for developing niosomes as a promising topical drug delivery platform. (2020) PHARMACEUTICS 1999-4923 12 3
* Sipos Bence et al. Quality by Design Based Formulation Study of Meloxicam-Loaded Polymeric Micelles for Intranasal Administration. (2020) PHARMACEUTICS 1999-4923 1999-4923 12 8
Tashima Toshihiko. Shortcut Approaches to Substance Delivery into the Brain Based on Intranasal Administration Using Nanodelivery Strategies for Insulin. (2020) MOLECULES 1420-3049 1420-3049 25 21
